These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

241 related articles for article (PubMed ID: 6825994)

  • 1. Pachydermoperiostosis, hypertrophic gastropathy, and peptic ulcer.
    Lam SK; Hui WK; Ho J; Wong KP; Rotter JI; Samloff IM
    Gastroenterology; 1983 Apr; 84(4):834-9. PubMed ID: 6825994
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of Helicobacter pylori on gastritis, pentagastrin-stimulated gastric acid secretion, and meal-stimulated plasma gastrin release in the absence of peptic ulcer disease.
    Hurlimann S; Dür S; Schwab P; Varga L; Mazzucchelli L; Brand R; Halter F
    Am J Gastroenterol; 1998 Aug; 93(8):1277-85. PubMed ID: 9707051
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Improvement in serum pepsinogens and gastrin in long-term monitoring after eradication of Helicobacter pylori: comparison with H. pylori-negative patients.
    Ohkusa T; Miwa H; Nomura T; Asaoka D; Kurosawa A; Sakamoto N; Abe S; Hojo M; Terai T; Ogihara T; Sato N
    Aliment Pharmacol Ther; 2004 Jul; 20 Suppl 1():25-32. PubMed ID: 15298602
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Diagnostic usefulness of serum group I pepsinogen determination.
    Peyre S; Di Napoli A; Pelissero A; Sategna-Guidetti C
    Gastroenterol Clin Biol; 1983 Oct; 7(10):793-8. PubMed ID: 6628912
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Screening of atrophic gastritis and gastric cancer by serum pepsinogen, gastrin-17 and Helicobacter pylori immunoglobulin G antibodies.
    Cao Q; Ran ZH; Xiao SD
    J Dig Dis; 2007 Feb; 8(1):15-22. PubMed ID: 17261130
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Duodenal-ulcer disease associated with elevated serum pepsinogen I: an inherited autosomal dominant disorder.
    Rotter JI; Sones JQ; Samloff IM; Richardson CT; Gursky JM; Walsh JH; Rimoin DL
    N Engl J Med; 1979 Jan; 300(2):63-6. PubMed ID: 758579
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Functional and provocative tests for gastroduodenal disorders.
    Walsh JH
    J Clin Gastroenterol; 1981; 3(Suppl 2):73-8. PubMed ID: 7320472
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of Helicobacter pylori eradication on gastric histology, serum gastrin and pepsinogen I levels, and gastric emptying in patients with gastric ulcer.
    Maconi G; Lazzaroni M; Sangaletti O; Bargiggia S; Vago L; Bianchi Porro G
    Am J Gastroenterol; 1997 Oct; 92(10):1844-8. PubMed ID: 9382049
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical usefulness of serum pepsinogens I and II, gastrin-17 and anti-Helicobacterpylori antibodies in the management of dyspeptic patients in primary care.
    Germaná B; Di Mario F; Cavallaro LG; Moussa AM; Lecis P; Liatoupolou S; Comparato G; Carloni C; Bertiato G; Battiestel M; Papa N; Aragona G; Cavestro GM; Iori V; Merli R; Bertolini S; Caruana P; Franzé A
    Dig Liver Dis; 2005 Jul; 37(7):501-8. PubMed ID: 15975537
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Potentialities of a serological method in diagnosis of atrophic gastritis].
    Pimenov SI; Makarenko EV
    Ter Arkh; 2008; 80(2):15-21. PubMed ID: 18372589
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Site of peptic ulcer. comparison of hydrochloric acid output, pepsinogen and gastrin serum levels.
    Engler-Pinto Júnior P; Gama-Rodrigues J; Lopasso FP; Cordeiro AC; Saez-Alquezar A; Laudanna AA; Pinotti HW
    Hepatogastroenterology; 1996; 43(12):1671-7. PubMed ID: 8975987
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Influence of bacterial CagA status on gastritis, gastric function indices, and pattern of symptoms in H. pylori-positive dyspeptic patients.
    Parente F; Imbesi V; Maconi G; Cucino C; Sangaletti O; Vago L; Bianchi Porro G
    Am J Gastroenterol; 1998 Jul; 93(7):1073-9. PubMed ID: 9672333
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Diagnostic value of serum pepsinogen C in patients with raised serum concentrations of pepsinogen A.
    Biemond I; Kreuning J; Jansen JB; Lamers CB
    Gut; 1993 Oct; 34(10):1315-8. PubMed ID: 8244094
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Changes in the histology and function of gastric mucosa and in Helicobacter pylori colonization during a long-term follow-up period after vagotomy in duodenal ulcer patients.
    Peetsalu M; Valle J; Härkönen M; Maaroos HI; Peetsalu A
    Hepatogastroenterology; 2005; 52(63):785-91. PubMed ID: 15966205
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pepsinogens and other physiologic markers in genetic studies of peptic ulcer and related disorders.
    Rotter JI; Petersen GM; Samloff IM
    Prog Clin Biol Res; 1985; 173():227-44. PubMed ID: 3885252
    [No Abstract]   [Full Text] [Related]  

  • 16. [Comparative study between seric I pepsinogen and seric gastrin, in the differentiation of the different types and localizations of chronic gastritis].
    Sánchez Rodríguez A; Martín Oterino JA; Chimpen Ruiz V; Alonso Hernández P; Araoz Sánchez P; Portugal Alvarez J
    An Med Interna; 1996 Dec; 13(12):576-9. PubMed ID: 9063931
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Hypertrophic gastropathy, resembling Ménétrier's disease, in transgenic mice with overexpression of TGF-alpha in the stomach].
    Lamberts R; Ramadori G
    Z Gastroenterol; 1994 Jan; 32(1):33-5. PubMed ID: 8147039
    [No Abstract]   [Full Text] [Related]  

  • 18. Genetic and evolutionary implications in peptic ulcer disease.
    Petersen GM; Rotter JI
    Am J Phys Anthropol; 1983 Sep; 62(1):71-9. PubMed ID: 6624902
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Helicobacter pylori eradication improves gastric histology and decreases serum gastrin, pepsinogen I and pepsinogen II levels in patients with duodenal ulcer.
    Pimanov SI; Makarenko EV; Voropaeva AV; Matveenko ME; Voropaev EV
    J Gastroenterol Hepatol; 2008 Nov; 23(11):1666-71. PubMed ID: 17559360
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical use of proton-pump inhibitors but not H2-blockers or antacid/alginates raises the serum levels of amidated gastrin-17, pepsinogen I and pepsinogen II in a random adult population.
    Agréus L; Storskrubb T; Aro P; Ronkainen J; Talley NJ; Sipponen P
    Scand J Gastroenterol; 2009; 44(5):564-70. PubMed ID: 19263272
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.